PILA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Pila Pharma AB operates as a clinical stage biotechnology company. It develops pharmaceutical products for the treatment of diabetes. The company was founded by Dorte Xenia Gram in 2014 and is headquartered in Malmo, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
PILA has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company